Peptyde Bio
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Peptyde Bio was an ag-tech startup in St. Louis, Missouri, founded in 2022 as the first company launched by the Danforth Technology Company (a subsidiary of the Donald Danforth Plant Science Center). It discovered, designed and characterised novel antimicrobial peptides (AMPs) as bio-fungicides — environmentally friendly alternatives to chemical fungicides, derived from plants and developed with AI — to protect crops from fungal diseases. Its investors included Invaio, BioGenerator Ventures, the Wells Fargo Innovation Incubator and the Danforth Center.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company launched
Danforth Technology Company announces Peptyde Bio as its first startup, co-founded by Danforth Center scientists Dilip Shah and Kirk Czymmek, to commercialise antimicrobial peptide bio-fungicides.
- Acquired by Invaio
In December 2023 Peptyde Bio is acquired by Invaio Sciences, a Cambridge, Massachusetts-based agriculture company; financial terms are not disclosed.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.